GLP-1 medications enhance insulin sensitivity and reduce insulin resistance, leading to improved blood sugar control even in individuals without diabetes
One spillover effect could be an increase in productivity, Hatzius said, citing academic studies that found obese individuals are less likely to work and to be less productive at work "These estimates therefore suggest that obesity-related health complications subtract over 3% from per-capita output, implying an over 1% hit to total output when combined with the over 40% incidence of obesity in the US population," Hatzius said
Think of it as a biomechanical brake, not a metabolic accelerator
It must be highlighted that rat skeletal muscle TC increases ~ 5070% following 4 weeks of LC supplementation [33, 34], whereas comparable elevation has never been observed in human studies, even after 24 weeks of supplementation [5, 7]
Because Novo Nordisk failed to include these side effects in the drugs prescribing information, many people have started taking Ozempic without properly understanding the risks associated with this particular diabetes drug
CJC-1295 is not FDA-approved for general clinical use, and treatment should always be guided by a licensed provider
